Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Intermediate Storage of Bulk Injectable Products – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Intermediate Storage of Bulk Injectable Products – V 2.0

Standard Operating Procedure for Intermediate Storage of Bulk Injectable Products


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/037/2025
Supersedes SOP/SIM/037/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP describes the standard procedure for intermediate storage of bulk injectable solutions prior to the filling stage, ensuring product integrity, traceability, and compliance with GMP and WHO standards.

2. Scope

This SOP applies to all batches of

bulk injectable products held temporarily during sterile manufacturing within designated intermediate storage tanks or vessels in the sterile area.

3. Responsibilities

  • Manufacturing Operator: Transfers and stores bulk solutions per batch record and SOP instructions.
  • Supervisor: Monitors and documents storage conditions and timelines.
  • QA Officer: Verifies adherence to storage specifications and performs line clearance.
  • Engineering: Ensures calibration and maintenance of storage vessels and monitoring equipment.
See also  Sterile Injectable Manufacturing: SOP for Lyophilization Process in Injectable Manufacturing - V 2.0

4. Accountability

The Head of Manufacturing is accountable for ensuring that all bulk injectable materials are stored under validated conditions and within defined hold times, as per the product-specific requirements.

5. Procedure

5.1 Preparation for Storage

  1. Ensure the bulk solution transfer line is sterilized and integrity-verified.
  2. Verify the receiving vessel (e.g., intermediate storage tank) has been cleaned and sterilized per SOP/SIM/032/2025.
  3. Affix status label on the vessel indicating “Ready for Use.”

5.2 Transfer and Storage

  1. Transfer bulk injectable solution under Grade A/B environment using aseptic technique.
  2. Document the start and end time of transfer in the Bulk Transfer Log (Annexure-1).
  3. Ensure storage temperature is maintained between 20°C to 25°C (unless product-specific range is defined).
  4. Seal all ports and cover with sterile caps post-transfer.

5.3 Storage Monitoring

  1. Monitor and record the vessel temperature every 30 minutes during hold time (Annexure-2).
  2. QA shall review temperature logs for compliance during batch record review.
  3. If any deviation is observed in temperature or seal integrity, initiate deviation report immediately.
See also  Sterile Injectable Manufacturing: SOP for Compatibility Studies of Container Closure Systems - V 2.0

5.4 Time Limit for Hold

  1. The maximum hold time must not exceed the time established in the process validation report or product master formula (e.g., 48 hours).
  2. Document start and expiry of hold time on the Batch Manufacturing Record (BMR).
  3. QA must authorize further processing if time limits are about to lapse.

5.5 Post-Storage Processing

  1. Verify all conditions (temp, duration, microbial limits) before proceeding to the filling stage.
  2. Use dedicated transfer lines to move the solution to the filling machine under aseptic conditions.
  3. Clean and sterilize intermediate vessels after each batch cycle and document in the Equipment Cleaning Log.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • WHO: World Health Organization

7. Documents

  1. Bulk Transfer Log – Annexure-1
  2. Temperature Monitoring Log – Annexure-2
  3. Storage Hold Time Verification Sheet – Annexure-3

8. References

  • WHO TRS 961: GMP for Sterile Pharmaceutical Products
  • EU GMP Annex 1
  • ICH Q7: Good Manufacturing Practice Guidance
See also  Sterile Injectable Manufacturing: SOP for Validation of Cleaning Processes for Sterile Equipment - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Bulk Transfer Log

Date Batch No. Start Time End Time Transferred By Verified By (QA)
18/06/2025 IV-4521 10:00 10:35 Manoj Kumar Neha Shah

Annexure-2: Temperature Monitoring Log

Date Time Temperature (°C) Checked By Remarks
18/06/2025 10:30 22.1 Anjali Sinha Within Range
18/06/2025 11:00 21.9 Anjali Sinha Within Range

Annexure-3: Storage Hold Time Verification Sheet

Batch No. Hold Start Time Hold End Time Duration (Hours) Verified By
IV-4521 10:35 22:35 12 Sunita Reddy

Revision History

Revision Date Revision No. Details Reason Approved By
10/02/2022 1.0 Initial release New SOP QA Head
18/06/2025 2.0 Added hold time verification table and updated monitoring log Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Aerosol: SOP for Managing Material Reconciliation in Manufacturing – V 2.0
Next Post: API Manufacturing: SOP for Quality Risk Management using FMEA – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version